---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-26-076085"
form_type: "8-K"
ticker: "SEM"
cik: "0001320414"
company_name: "SELECT MEDICAL HOLDINGS CORP"
filed_at: "2026-06-22T11:38:15+00:00"
generated_at: "2026-06-22T11:40:16.457093+00:00"
event_type: "litigation"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Select Medical supplements merger proxy with deal fees, DCF details after stockholder suits

## Summary
- Three lawsuits in NY and PA allege proxy omissions; company denies but voluntarily adds disclosures.
- Adds $2.9M fee to Ortenzio and $0.2M to Jackson for roles in structuring the transaction.
- Board explored separating critical illness recovery hospital segment from late June 2025.
- Goldman Sachs DCF valuation range per share: $15.04-$25.33; net debt $1.818B; 17 precedent deal premia added.
- Special meeting on merger remains scheduled for June 26, 2026; company urges stockholders to vote.

## SEC filing metadata
- accession: 0001104659-26-076085
- form_type: 8-K
- ticker: SEM
- cik: 0001320414
- company_name: SELECT MEDICAL HOLDINGS CORP
- filed_at: 2026-06-22T11:38:15+00:00
- event_type: litigation
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1320414/000110465926076085/0001104659-26-076085-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1320414/000110465926076085/tm2618429d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-26-076085
- JSON: https://secwatch.observer/filing/0001104659-26-076085.json
- Plain text: https://secwatch.observer/filing/0001104659-26-076085.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.